Cargando…

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction

Detalles Bibliográficos
Autores principales: Makdisse, MRP, Correa, AG, Knobel, M, Lagudis, S, Bacal, F, Morhy, SS, Fischer, CH, Vieira, MLC, Filho, EBL, Yokota, PKO, Knobel, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301170/
http://dx.doi.org/10.1186/cc5830
_version_ 1782226446612168704
author Makdisse, MRP
Correa, AG
Knobel, M
Lagudis, S
Bacal, F
Morhy, SS
Fischer, CH
Vieira, MLC
Filho, EBL
Yokota, PKO
Knobel, E
author_facet Makdisse, MRP
Correa, AG
Knobel, M
Lagudis, S
Bacal, F
Morhy, SS
Fischer, CH
Vieira, MLC
Filho, EBL
Yokota, PKO
Knobel, E
author_sort Makdisse, MRP
collection PubMed
description
format Online
Article
Text
id pubmed-3301170
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33011702012-03-14 Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction Makdisse, MRP Correa, AG Knobel, M Lagudis, S Bacal, F Morhy, SS Fischer, CH Vieira, MLC Filho, EBL Yokota, PKO Knobel, E Crit Care Poster Presentation BioMed Central 2007 2007-06-19 /pmc/articles/PMC3301170/ http://dx.doi.org/10.1186/cc5830 Text en Copyright ©2007 BioMed Central Ltd
spellingShingle Poster Presentation
Makdisse, MRP
Correa, AG
Knobel, M
Lagudis, S
Bacal, F
Morhy, SS
Fischer, CH
Vieira, MLC
Filho, EBL
Yokota, PKO
Knobel, E
Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title_full Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title_fullStr Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title_full_unstemmed Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title_short Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
title_sort increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301170/
http://dx.doi.org/10.1186/cc5830
work_keys_str_mv AT makdissemrp increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT correaag increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT knobelm increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT lagudiss increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT bacalf increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT morhyss increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT fischerch increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT vieiramlc increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT filhoebl increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT yokotapko increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction
AT knobele increaseinprescriptionrateofangiotensinconvertingenzymeinhibitorsorangiotensinreceptorblockerforhospitalizedpatientswithacutemyocardialinfarctionandleftventricularsystolicdysfunction